Unknown

Dataset Information

0

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.


ABSTRACT: To determine if the radiomic features on CT can predict progression-free survival (PFS) in epidermal growth factor receptor (EGFR) mutant adenocarcinoma patients treated with first-line EGFR tyrosine kinase inhibitors (TKIs) and to identify the incremental value of radiomic features over conventional clinical factors in PFS prediction.In this institutional review board-approved retrospective study, pretreatment contrast-enhanced CT and first follow-up CT after initiation of TKIs were analyzed in 48 patients (M:F = 23:25; median age: 61 years). Radiomic features at baseline, at 1st first follow-up, and the percentage change between the two were determined. A Cox regression model was used to predict PFS with nonredundant radiomic features and clinical factors, respectively. The incremental value of radiomic features over the clinical factors in PFS prediction was also assessed by way of a concordance index.Roundness (HR: 3.91; 95% CI: 1.72, 8.90; P = 0.001) and grey-level nonuniformity (HR: 3.60; 95% CI: 1.80, 7.18; P<0.001) were independent predictors of PFS. For clinical factors, patient age (HR: 2.11; 95% CI: 1.01, 4.39; P = 0.046), baseline tumor diameter (HR: 1.03; 95% CI: 1.01, 1.05; P = 0.002), and treatment response (HR: 0.46; 95% CI: 0.24, 0.87; P = 0.017) were independent predictors. The addition of radiomic features to clinical factors significantly improved predictive performance (concordance index; combined model = 0.77, clinical-only model = 0.69, P<0.001).Radiomic features enable PFS estimation in EGFR mutant adenocarcinoma patients treated with first-line EGFR TKIs. Radiomic features combined with clinical factors provide significant improvement in prognostic performance compared with using only clinical factors.

SUBMITTER: Kim H 

PROVIDER: S-EPMC5669442 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.

Kim Hyungjin H   Park Chang Min CM   Keam Bhumsuk B   Park Sang Joon SJ   Kim Miso M   Kim Tae Min TM   Kim Dong-Wan DW   Heo Dae Seog DS   Goo Jin Mo JM  

PloS one 20171103 11


<h4>Purpose</h4>To determine if the radiomic features on CT can predict progression-free survival (PFS) in epidermal growth factor receptor (EGFR) mutant adenocarcinoma patients treated with first-line EGFR tyrosine kinase inhibitors (TKIs) and to identify the incremental value of radiomic features over conventional clinical factors in PFS prediction.<h4>Methods</h4>In this institutional review board-approved retrospective study, pretreatment contrast-enhanced CT and first follow-up CT after ini  ...[more]

Similar Datasets

| S-EPMC10656631 | biostudies-literature
| S-EPMC7354146 | biostudies-literature
| S-EPMC10322215 | biostudies-literature
| S-EPMC9253544 | biostudies-literature
| S-EPMC8005341 | biostudies-literature
| S-EPMC7606974 | biostudies-literature
| S-EPMC5363800 | biostudies-literature
| S-EPMC6684898 | biostudies-other
| S-EPMC9485677 | biostudies-literature
| S-EPMC7553896 | biostudies-literature